Severe infections after bone marrow transplantation.

Area of Science:

• Hematology
• Critical Care Medicine
• Immunology

Background:

• Bone marrow and stem cell transplantation are standard curative therapies for hematologic malignancies and immunologic disorders.
• Severe infections are a major cause of morbidity and mortality post-transplantation, frequently necessitating intensive care unit (ICU) admission.
• Historically, ICU survival rates for transplant recipients, especially those requiring mechanical ventilation for respiratory failure, have been poor.

Purpose of the Study:

• To review the current understanding of critical illness in transplant recipients.
• To explore factors influencing outcomes and the role of intensive care.
• To emphasize the importance of early intensivist involvement for improving survival.

Main Methods:

• Review of existing literature on critical illness and intensive care in bone marrow and stem cell transplant patients.
• Analysis of factors contributing to morbidity and mortality, including infection and organ failure.
• Discussion of recent trends in supportive care and patient selection.

Main Results:

• A significant proportion (20-40%) of transplant patients require ICU admission post-transplantation.
• Respiratory failure requiring mechanical ventilation is a strong negative prognostic indicator.
• Recent studies suggest modest improvements in outcomes, though the reasons remain unclear.

Conclusions:

• Early involvement of intensivists is crucial for managing critical illness in transplant recipients.
• Further research is needed to define risk factors and optimize supportive care strategies.
• Improving survival in this vulnerable patient population remains a key objective in transplantation medicine.